Matthew Denholtz

Matthew Denholtz has a diverse work experience in the field of genomics and bioinformatics. Matthew worked at Fate Therapeutics Inc as an Associate Director in Molecular Engineering and previously held positions as a Principal Scientist and Senior Scientist in the field of Genomics. Prior to that, they worked as a Scientist in Genomics at the same company. Matthew also has experience as a Postdoctoral Fellow at UC San Diego, where they focused on multi-modal epigenomic and transcriptomic characterization of the human neutrophil's response to pathogen encounter. Matthew Denholtz also has research experience as a Postdoctoral Researcher and a Graduate Student Researcher at UCLA, where they specialized in genome organization. Furthermore, they have worked as a Research Assistant II at Beth Israel Deaconess Medical Center/Harvard Medical School, focusing on assessing the efficacy of potential HIV and SIV vaccine delivery systems. Matthew started their career as an Undergraduate Student Researcher at Gettysburg College.

Matthew Denholtz completed their education with a Ph.D. in Molecular Biology from UCLA, spanning from 2007 to 2013. Prior to that, they obtained a Bachelor of Science degree in Biochemistry/Molecular Biology from Gettysburg College, which they completed from 2001 to 2005. Matthew also has additional certifications in project management, R programming, leadership, Docker, and mathematics for machine learning. The specific dates of obtaining these certifications are not provided.